Related articles: Antibiotics under special circumstances, Effects of bacteria and viruses on their human host, Successive infection and variability in disease
Related articles: Antibiotics under special circumstances, Effects of bacteria and viruses on their human host, Successive infection and variability in disease
The white blood cell count rises in cases of infection, steroid use and other conditions.
The immune system responds to cues in the microenvironment to make acute and chronic adaptations in response to inflammation and injury. The therapeutic significance of adenosine-mediated effects on the immune system is discussed here. 1)
The term acute infection is used to refer to microbe living inside a host for a limited period of time, typically less than six months. However, an abundance of research has emerged suggesting that acute infections have long-lasting effects, predisposing a person to later onset of chronic diseases.
The purpose of the Marshall Protocol is to rehabilitate the immune response and improve the mix of microbes in the human body. In theory, this would free the immune response to target acute infections. Anecdotal reports from physicians and patients suggest that the MP is effective in this manner. To date, there have been no reports of tuberculosis or AIDS among MP patients.
Related section: Can chronic infections really cause disease?
When compatible high dose ABx is required for Acute bacterial infection see short term non MP antibiotic treatment in acute infection.
<html>Acute infections</html> | Chronic infections | |
---|---|---|
Terms | early, acute | late, chronic, fastidious, latent; an important type of chronic infection is the l-form |
Duration | lasts no more than six months (although, as we'll see below, the effects of acute infections can be long-lived) | lasts more than six months |
Rate of growth | fast - reproduce over the course of days | slow – may take several weeks to reproduce; build up over the course of decades (for example, the velocity of DNA replication fork progression for Mycoplasma reproduces ten times slower than Escherichia coli2)) |
Ease of study | present their own problems but more recognized and studied | relatively difficult – fewer markers, more challenging to infer causation |
Note that it is commonplace for a given species to morph between forms.
Certainly the exposure to and acquisition of new bacteria plays a role in the development of disease, but these factors don't account for everything. Diseases appear to strike randomly if for no other reason than their massive incidence and mortality. But, a close look at the evidence suggests that diseases tend to strike those who are most vulnerable. This is true even for acute infections such as the Black Death, the deadliest known epidemic in human history. The results of one analysis of 14th century skeletal remains found that “the Black Death did not kill indiscriminately - that it was, in fact, selective with respect to frailty….”3)
During the SARS epidemic, those who were succumbing were people with weakened immune systems, especially diabetics and healthcare workers.4) With the recent Escherichia coli O157:H7 epidemic, there appears to be a demographic pattern of patients who are likely already heavy carriers of a pathogenic microbiota. Remember that, like SARS, a lot more people are getting infected than those who actually fall ill and can't recover.
Trevor Marshall, PhD
According to the Marshall PathogenesisA description for how chronic inflammatory diseases originate and develop., “frailty” could just as easily refer to the strength of immune response. It is the absence of a robust immune response which is the primary contributing determinant in whether someone gets sick with chronic illness or someone remains healthy.
Bacterial pathogens themselves can make a human host more hospitable to their growth and reproduction by secreting substances like the sulfonolipid capnine, which bind and block the Vitamin D ReceptorA nuclear receptor located throughout the body that plays a key role in the innate immune response., a nuclear receptorIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affects transcription. that controls the innate immune response. Over time, bacteria succeed in suppressing the immune response through a gradual process known as successive infection. In the absence of intervention, successive infectionAn infectious cascade of pathogens in which initial infectious agents slow the immune response and make it easier for subsequent infections to proliferate. is something of an inevitability as everyone who lives long enough will take on the aches, pains, memory loss, and other symptoms that are the hallmark of chronic disease.
Bacteria are allowed to further proliferate when a person consumes any number of immunosuppressive foods, drugs, supplements and other substances. These substances include: immunosuppressants, beta-lactam antibiotics such as penicillin, corticosteroids, and foods and supplements containing high levels of vitamin D. The consumption of such substances is at historical levels and may be largely responsible for the recent spike in chronic disease incidence.
There is broad support for the conclusion that early infections, especially acute infections, predispose a person to later onset of chronic diseases, diseases which are likely caused by chronic microbial infections. In a 2004 Science paper, Finch and Crimmins proposed that early infection burdened survivors with a “cohort morbidity phenotype,” which they carry with them throughout their lives.5)
Microbial infections make the body a more hospitable environment for other infections via two primary means: affecting both human host-cell pathways and the expression of human genes. This effect has been documented in a range of clinical and laboratory-based studies. O'Connor and team at the Centers for Disease Control and Prevention state, “At least 13 of 39 recently described infectious agents induce chronic syndromes.”6) The section Successive infection: early infections predispose a person to later chronic disease lists at least a dozen such examples.
A variety of conventional treatments address acute infections with no eye towards their effect on chronic microbes:
It remains unclear how most standard treatments for acute infections affect the immune response. This is especially true of antibiotics, the primary action of which may be, unexpectedly, to target the body's nuclear receptorsIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affect transcription..
Many of the antivirals, antibacterials, etc., do not do the same thing in vivo as medicine expects them to, and the lack of discrimination between immunopathologyA temporary increase in disease symptoms experienced by Marshall Protocol patients that results from the release of cytokines and endotoxins as disease-causing bacteria are killed. and immunosuppression in early stages of treatment may well determine which of the more serious cases proceed towards death.
Trevor Marshall, PhD
Some have speculated that vitamin D is protective against acute infections, but this has not been supported by the evidence.
The purpose of the Marshall Protocol is to rehabilitate the immune response and improve the mix of microbes in the human body. In theory, this would free the immune response to target acute infections. Anecdotal reports from physicians and patients suggest that the MP is effective in this manner. To date, there have been no reports of tuberculosis or AIDS among MP patients.
Main article: Acute respiratory infections
Related articles: Acute infections, Effects of bacteria and viruses on their human host
While it is certainly possible to contract an acute respiratory infection while on the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis., many symptoms of immunopathologyA temporary increase in disease symptoms experienced by Marshall Protocol patients that results from the release of cytokines and endotoxins as disease-causing bacteria are killed. mimic those of an acute respiratory infection. Adjusting one's antibiotics or olmesartan (Benicar)Medication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. can sometimes help a patient distinguish between the two. The MP tends to make no difference to the course of a common cold. Patients with acute respiratory infections can manage their infections with antiviral agents as well as medicines which palliate symptoms.